Henna: A potential cause of oxidative hemolysis and neonatal hyperbilirubinemia

被引:2
|
作者
Zinkham, WH [1 ]
Oski, FA [1 ]
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA
关键词
neonatal hyperbilirubinemia; henna; lawsone; glucose-6-phosphate dehydrogenase; oxidative hemolysis;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. To evaluate the in vitro oxidative potential of lawsone (2-hydroxy-1,4 naphthoquinone). Lawsone is a chemical present in henna, the crushed leaves of which are used worldwide as a cosmetic agent to stain the hair, skin, and nails. Methodology. Venous blood from glucose-6-phosphate dehydrogenase (G6PD)-normal and G6PD A(-) subjects were incubated with various amounts of lawsone for 2 hours at 37 degrees C Reduced glutathione and methemoglobin (MHb) levels were measured before and after incubation. Results. Final molar concentrations of lawsone in normal blood of 1.4, 2.8, 5.7, and 8.6 x 10(-3) mol/L increased MHb percentages from 0.5% to 2.2%, 8.3%, 9.5%, and 12.5%, respectively. In a G6PD A(-) blood, MHb percentages were 19.8%, 32.2%, 44.9%, and 53.9%. At a lawsone concentration of 2.8 x 10(-3) mol/L, blood from 15 healthy adults formed MHb percentages of 7.4% +/- 3.3% (+/-1 SD); in blood from 4 G6PD A(-) adults, percentages were 44.5%, 40.6%, 41.3%, and 42.8%. Simultaneous measurements of reduced glutathione revealed preincubation values of greater than 40 mg/100 mL of red cells in blood of healthy and G6PD A(-) subjects. Postincubation values were greater than 40 in blood of healthy subjects and less than 40 in blood of G6PD A(-) subjects. Conclusions. These in vitro observations indicate that lawsone is an agent capable of causing oxidative hemolysis. In regions of the world where there is a high incidence of G6PD deficiency and unexplained hyperbilirubinemia, oxidative hemolysis secondary to the cutaneous application of henna could be the initiating event.
引用
收藏
页码:707 / 709
页数:3
相关论文
共 50 条
  • [31] NEONATAL HYPERBILIRUBINEMIA
    DICKSTEIN, B
    [J]. JOURNAL OF THE ALBERT EINSTEIN MEDICAL CENTER, 1965, 13 (01): : 29 - +
  • [32] NEONATAL HYPERBILIRUBINEMIA
    BROWN, AK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1963, 185 (08): : 680 - 680
  • [33] NEONATAL HYPERBILIRUBINEMIA
    GEMELLI, M
    DELEO, S
    TUCCIO, G
    [J]. LANCET, 1990, 335 (8682): : 179 - 179
  • [34] Neonatal hyperbilirubinemia
    Matteo Dal Ben
    Silvia Gazzin
    Claudio Tiribelli
    [J]. Italian Journal of Pediatrics, 40 (Suppl 2)
  • [35] NEONATAL HYPERBILIRUBINEMIA
    WIESE, G
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 1983, 131 (04) : 193 - 203
  • [36] NEONATAL HYPERBILIRUBINEMIA
    BROWDY, S
    [J]. CLINICAL PEDIATRICS, 1966, 5 (02) : 126 - &
  • [37] Neonatal hyperbilirubinemia
    Schwoebel, A
    Gennaro, S
    [J]. JOURNAL OF PERINATAL & NEONATAL NURSING, 2006, 20 (01) : 103 - 107
  • [38] Neonatal Hyperbilirubinemia
    Lee, Brian
    Piersante, Tracy
    Calkins, Kara L.
    [J]. PEDIATRIC ANNALS, 2022, 51 (06): : E219 - E227
  • [39] IV IMMUNE GLOBULIN (IVIG) IN NEONATAL COOMBS-POSITIVE HYPERBILIRUBINEMIA - DOES IT REDUCE HEMOLYSIS
    HAMMERMAN, C
    VREMAN, HJ
    KAPLAN, M
    STEVENSON, DK
    [J]. PEDIATRIC RESEARCH, 1995, 37 (04) : A282 - A282
  • [40] NOVOBIOCIN AND NEONATAL HYPERBILIRUBINEMIA - AN INVESTIGATION OF RELATIONSHIP IN AN EPIDEMICOF NEONATAL HYPERBILIRUBINEMIA
    SUTHERLAND, J
    KELLER, WH
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1961, 101 (04): : 447 - +